Sarah Morgan
Share
“What’s the value-add of scaling our multichannel marketing to add a new patient-centric element of gamification?”
“MRL is worried about UGC before the sNDA’s PDUFA date.”
“We need big data so we can get analytics to prove the ROI on making our disruptive campaign programmatic.”
If you understood those three sentences, beware – you may be living in BuzzWorld. Why does it matter, when is it okay, and what can you do about it? See my most recent post for Intouch at Surviving Buzzworld: Beware the Buzzwords of Pharma Marketing http://ssshare.it/v8x4
